The estimated Net Worth of Jesse J Geiger is at least $16.7 Milione dollars as of 4 March 2024. Mr. Geiger owns over 40,000 units of Medpace Inc stock worth over $7,194,259 and over the last 8 years he sold MEDP stock worth over $7,587,148. In addition, he makes $1,883,880 as Chief Financial Officer e Chief Operating Officer - Laboratory Operations at Medpace Inc.
Jesse has made over 14 trades of the Medpace Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 40,000 units of MEDP stock worth $3,626,000 on 4 March 2024.
The largest trade he's ever made was exercising 48,148 units of Medpace Inc stock on 5 April 2019 worth over $693,813. On average, Jesse trades about 9,242 units every 85 days since 2016. As of 4 March 2024 he still owns at least 21,503 units of Medpace Inc stock.
You can see the complete history of Mr. Geiger stock trades at the bottom of the page.
Jesse J. Geiger, CPA, serves as Chief Financial Officer, Chief Operating Officer - Laboratory Operations of the Company. He joined Medpace in October 2007 as Corporate Controller, and he was appointed Chief Financial Officer in March 2011. Mr. Geiger became Chief Operating Officer, Laboratory Operations in November 2014. Prior to joining Medpace, Mr. Geiger worked for SENCORP from 2004 to 2007 as the Corporate Controller and Manager of Financial Planning and Analysis. Prior to SENCORP, Mr. Geiger served as the Director of Capital Markets for Cincinnati Bell from 2002 to 2004. Mr. Geiger started his career in the audit practice at Arthur Andersen LLP. Mr. Geiger has served as a director for several private companies, including as a director of LIB Therapeutics, LLC since 2015 and as a director of CinRx Pharma, LLC since 2015. Mr. Geiger received his Bachelor of Business Administration in Accounting from the University of Cincinnati and is a Certified Public Accountant.
As the Chief Financial Officer e Chief Operating Officer - Laboratory Operations of Medpace Inc, the total compensation of Jesse Geiger at Medpace Inc is $1,883,880. There are 2 executives at Medpace Inc getting paid more, with August Troendle having the highest compensation of $7,712,840.
Jesse Geiger is 45, he's been the Chief Financial Officer e Chief Operating Officer - Laboratory Operations of Medpace Inc since . There are 13 older and 1 younger executives at Medpace Inc. The oldest executive at Medpace Holdings Inc is Fred Davenport, 68, who is the Lead Independent Director.
Jesse's mailing address filed with the SEC is C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI, OH, 45227.
Over the last 8 years, insiders at Medpace Inc have traded over $3,140,136,825 worth of Medpace Inc stock and bought 2,899,276 units worth $330,034,155 . The most active insiders traders include Limited Partnership Medpace..., August J. Troendle e Investors, Llc Medpace. On average, Medpace Inc executives and independent directors trade stock every 9 days with the average trade being worth of $40,224,347. The most recent stock trade was executed by Robert O. Kraft on 22 August 2024, trading 8,127 units of MEDP stock currently worth $346,373.
a therapeutically focused leader in research-based drug development, medpace builds strong strategic partnerships with select sponsors to advance the most efficient and cost-effective path to drug approval. as a full service, global clinical research organization (cro), medpace sees itself as a steward of your drug, leveraging its extensive medical and regulatory expertise to deliver additional input, strategy, and efficiencies to each and every phase of the clinical trial. from custom solutions addressing the needs of small and midsize biotechnology companies to full-service offerings for global pharmaceutical companies, medpace has the breadth, depth, and flexibility to deliver a superior result, specific to your needs, on six continents.
Medpace Inc executives and other stock owners filed with the SEC include: